Hhlr Advisors, Ltd. Kronos Bio, Inc. Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.35 - $21.18 $1.74 Million - $3.26 Million	-153,698 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$18.17 - $24.7 $5.08 Million - $6.91 Million	-279,738 Reduced 64.54%	153,698 $3.22 Million
Q2 2021 Aug 16, 2021	SELL	$20.08 - $29.02 $4.52 Million - $6.53 Million	-225,000 Reduced 34.17%	433,436 $10.4 Million
Q4 2020 Feb 12, 2021	BUY	$26.68 - $38.23 $17.6 Million - $25.2 Million	658,436 New	658,436 $19.7 Million

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $51.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.